Sandbox:Javaria: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 57: | Line 57: | ||
❑ [[CMP]]<br> | ❑ [[CMP]]<br> | ||
❑ [[Peripheral smaer]]<br> | ❑ [[Peripheral smaer]]<br> | ||
❑ [[Liver function tests|LFTs]]}} | ❑ [[Liver function tests|LFTs]]<br> | ||
*''Labs may be required at a later stage pf diagnosis''}} | |||
{{familytree | | | | | | | | | | |!| | | | | | | }} | {{familytree | | | | | | | | | | |!| | | | | | | }} | ||
{{familytree | | | | | | | | | | |!| | | | | | | }} | {{familytree | | | | | | | | | | |!| | | | | | | }} | ||
Line 76: | Line 77: | ||
{{familytree | |!| | | |!| | |!| |!| |!| | |!|}} | {{familytree | |!| | | |!| | |!| |!| |!| | |!|}} | ||
{{familytree | |!| | |,|^|.| |!| |!| |!| | F01 |F01=Excisional biopsy}} | {{familytree | |!| | |,|^|.| |!| |!| |!| | F01 |F01=Excisional biopsy}} | ||
{{familytree | |!| B01 | | B02 | |!| |!| |,|^|-|.|B01=Positive|B02=Negative | {{familytree | |!| B01 | | B02 | |!| |!| |,|^|-|.|B01=Positive|B02=Negative}} | ||
{{familytree | |!| | |!| | | | | |!| |`| J01 | | J02 | |J01=Negative|J02=Positive}} | {{familytree | |!| | |!| | | | | |!| |`| J01 | | J02 | |J01=Negative|J02=Positive}} | ||
{{familytree | |!| | |!| | | | | |!| | | | | | | |!| | | |}} | {{familytree | |!| | |!| | | | | |!| | | | | | | |!| | | |}} | ||
Line 93: | Line 94: | ||
{{familytree | | | | | | A01 | | | | | A02 | | | | | | |A01= Low risk<br> |A02=High risk}} | {{familytree | | | | | | A01 | | | | | A02 | | | | | | |A01= Low risk<br> |A02=High risk}} | ||
{{familytree | | | | | | |!| | | | | | |!| | | | }} | {{familytree | | | | | | |!| | | | | | |!| | | | }} | ||
{{familytree | | | | | | |!| | | | | | B01 | | B01=<div style="float: left; text-align: left; line-height: 150% ">Specific tests}} | {{familytree | | | | | | |!| | | | | | B01 | | | | B01=<div style="float: left; text-align: left; line-height: 150% ">Specific tests/ [[biopsy]]}} | ||
{{familytree | | |,|-|-|-|^|-|. | {{familytree | | | | | | |!| | | | | | | | | }} | ||
{{familytree | | C01 | | | | | C02 | | | | | | | | |C01=Localized|C02=Generalized}} | {{familytree | | |,|-|-|-|^|-|-|.| | | | | | | | }} | ||
{{familytree | | | | | | | | | | | | | | | | | | }} | {{familytree | | C01 | | | | | | C02 | | | | | | | | |C01=Localized|C02=Generalized}} | ||
{{familytree | | | | | | | | | | | | | | | | | | | | |E01= }} | {{familytree | | |!| | | | | | | |!| | | | | | | | }} | ||
{{familytree | | D01 | | | | | | D02 | | | | | | | | | D01=Review history and clues suggesting malignancy|D02=Review history and clues suggesting malignancy}} | |||
{{familytree | | |!| | | | | | | |!| | | | | | | | }} | |||
{{familytree | | E01 | | | | | | E02 | | | | | | | |E01=Observe 3-4 weeks|E02=Specific tests such as [[CXR]], [[ultrasound]], [[CT]], lab workup, [[biopsy]]}} | |||
{{familytree | | |!| | | | | | |,|-|^|-|-|.| | | | | }} | |||
{{familytree | |,|^|-|.| | | | F01 | | | F02 | | | | |F01=Undiagnostic|F02=Diagnostic}} | |||
{{familytree | |!| | |!| | | | |!| | | | |!| | | | |}} | |||
{{familytree | L01 | |L02| | |!| | | | |!| | | | | | |L01=Progress/persists|L02=Regress}} | |||
{{familytree |!| | | |!| | | | |!| | | | |!| | | | | |}} | |||
{{familytree |!| | | |!| | | | G01 | | | G02 | | | | | | |G01= Biopsy|G02=Treatment}} | |||
{{familytree | | | | | | | |,|-|^|.| | | | | | | | | | |}} | |||
{{familytree | | | | | | | H01 | | H02 | | | | | | | | | |H01=Positive|H02=Negative }} | |||
{{familytree | | | | | | | |!| | | |!| | | | | | | | | |}} | |||
{{familytree | | | | | | | I01 | | I02 | | | | | | | | | |I01=Treatment|I02= Follow-up|}} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | |}} | |||
{{familytree/end}} | {{familytree/end}} |
Revision as of 11:46, 22 August 2020
.
History
| |||||||||||||||||||||||||||||||||||||||||||||
Physical exam Appearance of the patient Cachexia or surgical scar marks demonstrating previous malignancy treatment
❑ HEENT
❑ Extremities exam | |||||||||||||||||||||||||||||||||||||||||||||
Palpable lymph node ❑ Location: (Localized vs generalized)
❑ Dimensions
❑ Tenderness or pain:
❑ Consistency
❑ Mobility
| |||||||||||||||||||||||||||||||||||||||||||||
Labs ❑ CBC with differential
| |||||||||||||||||||||||||||||||||||||||||||||
Diagnostic of self-limiting or benign disease Pharyngitis, URTI, conjunctivitis, cat-scratch disease, etc | Suggests infection/ serious infection | Unexplained | Suggests malignancy | ||||||||||||||||||||||||||||||||||||||||||
May require specific tests | Perform specific tests ❑ IM: Heterophile Antibody and monospot test | Risk factors for malignancy Family history, age, exposure, etc | Perform specific tests | ||||||||||||||||||||||||||||||||||||||||||
Excisional biopsy | |||||||||||||||||||||||||||||||||||||||||||||
Positive | Negative | ||||||||||||||||||||||||||||||||||||||||||||
Negative | Positive | ||||||||||||||||||||||||||||||||||||||||||||
❑ Treat with antibiotics if required and/ or symptomatic treatment ❑ For an untreatable or disease with residual symptoms counsel the patient | Treat | ||||||||||||||||||||||||||||||||||||||||||||
Low risk | High risk | ||||||||||||||||||||||||||||||||||||||||||||
Specific tests/ biopsy | |||||||||||||||||||||||||||||||||||||||||||||
Localized | Generalized | ||||||||||||||||||||||||||||||||||||||||||||
Review history and clues suggesting malignancy | Review history and clues suggesting malignancy | ||||||||||||||||||||||||||||||||||||||||||||
Observe 3-4 weeks | Specific tests such as CXR, ultrasound, CT, lab workup, biopsy | ||||||||||||||||||||||||||||||||||||||||||||
Undiagnostic | Diagnostic | ||||||||||||||||||||||||||||||||||||||||||||
Progress/persists | Regress | ||||||||||||||||||||||||||||||||||||||||||||
Biopsy | Treatment | ||||||||||||||||||||||||||||||||||||||||||||
Positive | Negative | ||||||||||||||||||||||||||||||||||||||||||||
Treatment | Follow-up | ||||||||||||||||||||||||||||||||||||||||||||
- ↑ Garg PK, Jain BK, Dubey IB, Sharma AK (2013). "Generalized lymphadenopathy: physical examination revisited". Ann Saudi Med. 33 (3): 298–300. doi:10.5144/0256-4947.2012.01.7.1525. PMC 6078537. PMID 22750769.
- ↑ Mohseni S, Shojaiefard A, Khorgami Z, Alinejad S, Ghorbani A, Ghafouri A (March 2014). "Peripheral lymphadenopathy: approach and diagnostic tools". Iran J Med Sci. 39 (2 Suppl): 158–70. PMC 3993046. PMID 24753638.
- ↑ Bazemore AW, Smucker DR (December 2002). "Lymphadenopathy and malignancy". Am Fam Physician. 66 (11): 2103–10. PMID 12484692.
- ↑ Soldes OS, Younger JG, Hirschl RB (October 1999). "Predictors of malignancy in childhood peripheral lymphadenopathy". J. Pediatr. Surg. 34 (10): 1447–52. doi:10.1016/s0022-3468(99)90101-x. PMID 10549745.
- ↑ Ghirardelli ML, Jemos V, Gobbi PG (March 1999). "Diagnostic approach to lymph node enlargement". Haematologica. 84 (3): 242–7. PMID 10189390.